Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

318 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Secondary 12-Month Ocular Outcomes of a Phase 1 Dosing Study of Bevacizumab for Retinopathy of Prematurity.
Crouch ER, Kraker RT, Wallace DK, Holmes JM, Repka MX, Collinge JE, Bremer DL, Gray ME, Smith HA, Steinkuller PG; Writing Committee for Pediatric Eye Disease Investigator Group. Crouch ER, et al. Among authors: repka mx. JAMA Ophthalmol. 2020 Jan 1;138(1):14-20. doi: 10.1001/jamaophthalmol.2019.4488. JAMA Ophthalmol. 2020. PMID: 31697304 Free PMC article. Clinical Trial.
Surfactant prophylaxis and retinopathy of prematurity.
Repka MX, Hardy RJ, Phelps DL, Summers CG. Repka MX, et al. Arch Ophthalmol. 1993 May;111(5):618-20. doi: 10.1001/archopht.1993.01090050052027. Arch Ophthalmol. 1993. PMID: 8489440 Clinical Trial.
Early treatment of posterior retinopathy of prematurity: a controlled trial.
Vander JF, Handa J, McNamara JA, Trese M, Spencer R, Repka MX, Rubsamen P, Li H, Morse LS, Tasman WS. Vander JF, et al. Among authors: repka mx. Ophthalmology. 1997 Nov;104(11):1731-5; discussion 1735-6. doi: 10.1016/s0161-6420(97)30034-7. Ophthalmology. 1997. PMID: 9373099 Clinical Trial.
318 results